News Articles Tagged: Chemoresistance

Dihydromyricetin in Ovarian Cancer: Targeting Apoptosis and Overcoming Chemoresistance

Ningbo Innopharmchem presents research on dihydromyricetin's role in ovarian cancer, focusing on apoptosis induction, p53 activation, and reversal of chemoresistance through survivin downregulation. Buy DHM for research.

The Therapeutic Potential of Mithramycin A in Modern Oncology

A comprehensive look at Mithramycin A's therapeutic potential in oncology, focusing on its antineoplastic properties, impact on cancer stem cells, and overcoming drug resistance. NINGBO INNO PHARMCHEM CO.,LTD. is a key partner.

Mithramycin A: Investigating its Efficacy and Availability for Cancer Research

Learn about the latest research on Mithramycin A's efficacy in cancer treatment and explore options for research-grade material. NINGBO INNO PHARMCHEM CO.,LTD. is a key player in this field.

Mithramycin A: A Novel Approach to Overcoming Chemoresistance in Cancer

Discover how Mithramycin A combats chemoresistance by targeting SP1 and other mechanisms in cancer cells, offering a new therapeutic avenue. NINGBO INNO PHARMCHEM CO.,LTD. highlights its potential.